KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 146 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 3.32 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $104,000 | -25.2% | 77,281 | -0.0% | 0.00% | – |
| Q2 2023 | $139,000 | -43.0% | 77,297 | +23.2% | 0.00% | – |
| Q1 2023 | $244,000 | +11.9% | 62,752 | -2.3% | 0.00% | – |
| Q4 2022 | $218,000 | +257.4% | 64,229 | +474.8% | 0.00% | – |
| Q3 2022 | $61,000 | +3.4% | 11,175 | -16.1% | 0.00% | – |
| Q2 2022 | $59,000 | -52.0% | 13,321 | -19.6% | 0.00% | – |
| Q1 2022 | $123,000 | -38.5% | 16,567 | -46.7% | 0.00% | – |
| Q4 2021 | $200,000 | +29.0% | 31,077 | +16.5% | 0.00% | – |
| Q3 2021 | $155,000 | -30.8% | 26,679 | +22.9% | 0.00% | – |
| Q2 2021 | $224,000 | +88.2% | 21,700 | +91.3% | 0.00% | – |
| Q1 2021 | $119,000 | +29.3% | 11,344 | +90.7% | 0.00% | – |
| Q4 2020 | $92,000 | +13.6% | 5,950 | +6.2% | 0.00% | – |
| Q3 2020 | $81,000 | -22.1% | 5,600 | +1.1% | 0.00% | – |
| Q2 2020 | $104,000 | +593.3% | 5,539 | +614.7% | 0.00% | – |
| Q1 2020 | $15,000 | -53.1% | 775 | -52.2% | 0.00% | – |
| Q4 2019 | $32,000 | +68.4% | 1,620 | -14.7% | 0.00% | – |
| Q3 2019 | $19,000 | +137.5% | 1,900 | +46.2% | 0.00% | – |
| Q2 2019 | $8,000 | 0.0% | 1,300 | 0.0% | 0.00% | – |
| Q1 2019 | $8,000 | +166.7% | 1,300 | +333.3% | 0.00% | – |
| Q4 2018 | $3,000 | -88.9% | 300 | -81.2% | 0.00% | – |
| Q3 2018 | $27,000 | +800.0% | 1,595 | +942.5% | 0.00% | – |
| Q2 2018 | $3,000 | -62.5% | 153 | -75.1% | 0.00% | – |
| Q1 2018 | $8,000 | +14.3% | 615 | -13.9% | 0.00% | – |
| Q4 2017 | $7,000 | -82.5% | 714 | -80.5% | 0.00% | – |
| Q3 2017 | $40,000 | +400.0% | 3,669 | +330.1% | 0.00% | – |
| Q2 2017 | $8,000 | -57.9% | 853 | -42.4% | 0.00% | – |
| Q1 2017 | $19,000 | +11.8% | 1,482 | -17.2% | 0.00% | – |
| Q4 2016 | $17,000 | -5.6% | 1,790 | -0.6% | 0.00% | – |
| Q3 2016 | $18,000 | +100.0% | 1,800 | +28.6% | 0.00% | – |
| Q2 2016 | $9,000 | -97.7% | 1,400 | -96.8% | 0.00% | – |
| Q1 2016 | $388,000 | -75.9% | 43,600 | -64.1% | 0.00% | – |
| Q4 2015 | $1,609,000 | +6895.7% | 121,474 | +5497.9% | 0.00% | – |
| Q3 2015 | $23,000 | -4.2% | 2,170 | +141.1% | 0.00% | – |
| Q2 2015 | $24,000 | -14.3% | 900 | 0.0% | 0.00% | – |
| Q1 2015 | $28,000 | -86.7% | 900 | -85.0% | 0.00% | – |
| Q3 2014 | $210,000 | -74.5% | 6,000 | -66.1% | 0.00% | -100.0% |
| Q2 2014 | $824,000 | – | 17,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 7,180,700 | $137,941,000 | 10.27% |
| Palo Alto Investors LP | 4,299,901 | $82,601,000 | 6.92% |
| Fairmount Funds Management LLC | 562,351 | $10,803,000 | 6.55% |
| Avoro Capital Advisors LLC | 7,000,000 | $134,470,000 | 4.54% |
| Pinz Capital Management, LP | 8,820 | $1,694,000 | 4.44% |
| Birchview Capital, LP | 148,000 | $2,843,000 | 2.52% |
| Elk Creek Partners, LLC | 699,951 | $13,446,000 | 2.31% |
| Parkman Healthcare Partners LLC | 215,802 | $4,146,000 | 1.92% |
| EAM Global Investors LLC | 136,402 | $2,620,000 | 1.53% |
| SPHERA FUNDS MANAGEMENT LTD. | 550,000 | $10,566,000 | 1.32% |